Literature DB >> 17499924

Onset and progression of dystonia in complex regional pain syndrome.

Monique A van Rijn1, Johan Marinus, Hein Putter, Jacobus J van Hilten.   

Abstract

Complex regional pain syndrome (CRPS) may lead to movement disorders (MDs) in some patients. Reliable information on the nature, chronology and clinical determinants of MDs in CRPS patients is lacking but could provide better insight in to the underlying pathophysiological mechanism. We retrospectively evaluated the clinical and temporal characteristics of MDs in patients with CRPS. Cox's proportional hazards model was used to evaluate factors influencing the onset of MDs. One-hundred and eighty-five patients suffered CRPS in one or more extremities. MDs occurred in 121 patients, with dystonia (91%) being the most prevalent. Sixty-two percent of these patients displayed dystonia in multiple extremities. Patients with dystonia were on average 11 years younger and more often had CRPS in multiple extremities. The interval between the onset of CRPS and dystonia in the first affected extremity varied from less than 1 week in 26% of the patients to more than 1 year in 27%. The hazard of developing dystonia in subsequent extremities increased with the number of extremities affected by dystonia. We conclude that dystonia in CRPS shows highly variable onset latency and is associated with younger age at onset and increased risk of developing dystonia in other extremities. The delayed onset and progression of dystonia in CRPS may indicate the involvement of a different underlying mechanism, possibly associated with maladaptive neuroplasticity.

Entities:  

Mesh:

Year:  2007        PMID: 17499924     DOI: 10.1016/j.pain.2007.03.027

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  22 in total

Review 1.  Clinical features and pathophysiology of complex regional pain syndrome.

Authors:  Johan Marinus; G Lorimer Moseley; Frank Birklein; Ralf Baron; Christian Maihöfner; Wade S Kingery; Jacobus J van Hilten
Journal:  Lancet Neurol       Date:  2011-07       Impact factor: 44.182

Review 2.  Phenotype-specific diagnosis of functional (psychogenic) movement disorders.

Authors:  Alberto J Espay; Anthony E Lang
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

Review 3.  Posttraumatic functional movement disorders and litigation.

Authors:  P Santens; A Bruggeman
Journal:  Acta Neurol Belg       Date:  2021-03-27       Impact factor: 2.396

Review 4.  Complex regional pain syndrome type I: neuropathic or not?

Authors:  Dennis Naleschinski; Ralf Baron
Journal:  Curr Pain Headache Rep       Date:  2010-06

Review 5.  Complex regional pain syndrome: a narrative review for the practising clinician.

Authors:  H Shim; J Rose; S Halle; P Shekane
Journal:  Br J Anaesth       Date:  2019-05-02       Impact factor: 9.166

Review 6.  A key role of the basal ganglia in pain and analgesia--insights gained through human functional imaging.

Authors:  David Borsook; Jaymin Upadhyay; Eric H Chudler; Lino Becerra
Journal:  Mol Pain       Date:  2010-05-13       Impact factor: 3.395

Review 7.  Post-traumatic complex regional pain syndrome: clinical features and epidemiology.

Authors:  Chiara Ratti; Andrea Nordio; Giuseppina Resmini; Luigi Murena
Journal:  Clin Cases Miner Bone Metab       Date:  2016-04-07

Review 8.  Role of distorted body image in pain.

Authors:  Martin Lotze; G L Moseley
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.592

9.  Systematic mutation analysis of seven dystonia genes in complex regional pain syndrome with fixed dystonia.

Authors:  M Florencia Gosso; Annetje M de Rooij; Elisenda Alsina-Sanchis; Jessica T Kamphorst; Johan Marinus; Jacobus J van Hilten; Arn M J M van den Maagdenberg
Journal:  J Neurol       Date:  2010-01-12       Impact factor: 4.849

Review 10.  Transforming pain medicine: adapting to science and society.

Authors:  D Borsook; E Kalso
Journal:  Eur J Pain       Date:  2013-03-07       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.